A farmer in Ireland who was arrested for growing and selling cannabis from his farm received a suspended sentence. Currently, cannabis is illegal in Ireland, except within a limited medical program.
James Sinnott, a sheep farmer in Ireland who grew and distributed cannabis, was charged last month with three counts of possession of cannabis and avoided a two-year jail sentence (1).
“I have helped hundreds of people over the years,” Sinnott told reporters (1). “We helped people with Crohn’s disease, MS, cancer, people with brain tumors. And, over 10 years, I never made one penny out of it.”
Sinnott claims he sold the oil at cost price or gave it away for free to customers who could not afford it.
According to the website for the Garda (the Irish police): “It is an offence to cultivate, import, export, produce, supply and possess cannabis except in accordance with a Ministerial Licence,” (2). “Policy to date has not permitted the cultivation of cannabis for medical purposes and no licences have been issued for this activity.”
Sinnott said he became involved in growing and distributing cannabis more than a decade ago, after his father developed three forms of cancer. When their original supply of cannabis oil became unavailable, Sinnott started producing it himself. He said they used every part of the plant to make the oil, including the roots. He also distributed some of the plants to his customers and instructed them on how to make the oil themselves.
“I have the height of respect for the judge and guards,” Sinnott said. “They’re applying the law as is stands in the best way that they can. But that’s why the law needs to be changed. Cannabis oil should be supplied to the people in this country like it is in other jurisdictions without seriously ill people having to go through hell to get it. Even if it doesn’t work for everyone, and I’m not saying it does, at least give people the chance to try it for themselves.”
While the judge believed Sinnott’s choice to break the law to help ill patients was misguided, he did acknowledge that he made no profit from it and imposed a suspended two-year jail term on the condition of good behavior (1).
“To me, when I was in court, facing five to seven years, it meant nothing to me compared to all the years we have given back to people while we were doing this,” said Sinnott. With his conviction and the publicity, he can no longer make the oil and worries that his customers will turn to “con artists” who could be selling overpriced or false products (1).
For more resources on cannabis laws in Ireland please see: https://cannigma.com/regulation/ireland-marijuana-laws/ and https://www.patientsforsafeaccess.com/
References
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Khan
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
German Medical Cannabis Market Has Yet to Reach Its Full Potential
December 25th 2024Germany’s Cannabis Act (CanG) is beginning to transform the country's medical cannabis market, with potential opportunities to expand telemedicine, improve physician training, and enhancing accessibility in this rapidly growing industry.